Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11347-11355
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11347
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11347
Figure 5 Upregulation of miR-218 inhibited gastric tumor growth in vivo.
Cells stably expressing miR-218 or miR-NC were incubated in Dulbecco's modified Eagle’s medium and subcutaneously injected into each side of the posterior flank of nude mice (n = 24). Thirty-three days after injection, mice were sacrificed and tumors were removed. A: Tumor volume at 33 d; B: Tumor volumes were detected every three days from the time they were obvious; C: Average tumor weights. aDenoted statistical significance between the two groups of miR-218 and control. aP < 0.05 vs control.
- Citation: Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB, Fang ZY, Cui SZ, Wang LT. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World J Gastroenterol 2014; 20(32): 11347-11355
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11347.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11347